Cite
MLA Citation
Giancarlo Comi et al.. “Efficacy of alemtuzumab in relapsing-remitting MS patients who received additional courses after the initial two courses: Pooled analysis of the CARE-MS, extension, and TOPAZ studies.” Multiple sclerosis, vol. 26, 2020, pp. 1866–1876. http://access.bl.uk/ark:/81055/vdc_100111435681.0x00001b